ongoing
completed
TARGET
Renal
The TARGET trial investigated intensive versus liberalized phosphate control in hemodialysis recipients. The objective of...
completed
PHASE
Renal
Mineralocorticoid receptor antagonism reduces morbidity and mortality in patients with heart failure, but the safety...
completed
416858-CS4
Renal
The objective of the 416858-CS4 study was to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics...
